Health Desk, May 17, 2017: National Institute of Cardiovascular Diseases (NICVD) is expanding its healthcare facilities, including the allocation of a lifesaving drug for acute heart attack victims.
The free supply of Streptokinase injection, which is used for dissolving coronary blocks, was earlier limited to only 100 patients every month. But it’s a matter of great joy that from now on, all the patients who need it will be supplied by the authority at the hospital.
Director of the NICVD Prof Dr Afzalur Rahman said, "Earlier, we used to provide the injection to maximum 100 patients every month. Now there is no limit to it. Whoever needs it, will get it for free".
Any hospital staff, if found advising patients to buy the drug from outside, will face punitive actions, he added.
He also said around 500 patients need the injection at the hospital every month.
Professor AHM Enayet Hussain, additional director general at the Directorate General of Health Services, said the initiative by the NICVD is even more laudable because it has expanded services with its own funds.